George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,093.00
Bid: 1,093.00
Ask: 1,099.00
Change: 2.00 (0.18%)
Spread: 6.00 (0.549%)
Open: 1,080.00
High: 1,098.00
Low: 1,073.00
Prev. Close: 1,091.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FCA letter re Release of Preliminary Results

23 Mar 2020 10:59

RNS Number : 1873H
Fevertree Drinks PLC
23 March 2020
 

23rd March 2020

Fevertree Drinks plc

 ("Fever-Tree" or the "Group")

  

FCA letter re Temporary Moratorium on Release of Preliminary Results

The FCA issued guidance on 21 March 2020 requesting public companies to delay the announcement of Preliminary Results for at least two weeks, due to the challenges caused by the Coronavirus crisis. Consequently, while Fever-Tree intended to announce its Preliminary Results for the year ended 31 December 2019 on 24 March 2020, the Group will follow the FCA's request and confirms that it will defer the publication of its results.

Fever-Tree is a global business with revenue diversified across regions, channels and customers. Notwithstanding tough comparators in the UK, the Group has made a solid start to the new financial year, with trading in the first two months in line with the Board's expectations, with the US in particular seeing strong trading.

However, given the current high level of uncertainty it is too early to quantify the impact the COVID-19 crisis will have on the outturn for the remainder of the 2020 financial year and therefore the Board is not able to provide financial guidance at this stage.

Our focus, first and foremost, is on the health and wellbeing of our employees, customers and partners across all our regions. Whilst we will face challenges in the coming months, financially the Group is extremely secure. We are debt free, with a year-end cash position of £128m underpinned by strong cash flows. The Group's unique asset light, outsourced business model means we have a low fixed cost base, a small, dedicated team and the flexibility to manage the significant challenges ahead.

The Group will await further guidance from the FCA with regard to the timing of the publication of its Preliminary Results. 

For further information:

 

Fevertree Drinks plc  +44 (0)20 7349 4922

Tim Warrillow, Co-founder and CEO

Andy Branchflower, CFO

Oliver Winters, Communications & IR Director

 

Numis Securities - Nominated Adviser and Joint Broker +44 (0)20 7260 1000

Garry Levin

Matt Lewis

Hugo Rubinstein

 

Investec Bank plc - Joint Broker +44 (0)20 7597 5970

David Flin

Alex Wright

David Anderson 

 

Brunswick Group +44 (0) 20 7404 5959

Jonathan Glass

Fiona Micallef-Eynaud

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLFEIVIIVFII
Date   Source Headline
27th Mar 20247:00 amRNSHolding(s) in Company
26th Mar 20247:00 amRNSFY23 Preliminary Results to 31 December 2023
25th Jan 202412:05 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSFY23 pre-close trading update
18th Jan 20242:30 pmRNSAdmission Application
18th Jan 20242:30 pmRNSBlock Admission Application
14th Dec 20232:33 pmRNSDirectorate Change
1st Dec 20237:00 amRNSBlock Listing Return
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20238:55 amRNSTotal Voting Rights
26th Oct 20233:25 pmRNSDirector/PDMR Shareholding
28th Sep 20236:20 pmRNSHolding(s) in Company
14th Sep 202312:18 pmRNSDirector/PDMR Shareholding
12th Sep 20236:25 pmRNSFever-Tree FY23 Interim Results - Replacement
12th Sep 20237:00 amRNSFever-Tree FY23 Interim Results
1st Aug 20232:16 pmRNSTotal Voting Rights
3rd Jul 20234:00 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSBlock Listing Return
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20231:54 pmRNSResult of AGM
25th May 20237:00 amRNSBoard Changes
25th May 20237:00 amRNSAGM Trading Statement
12th May 202311:25 amRNSHolding(s) in Company
5th May 20237:00 amRNSGrant of Options
2nd May 20237:00 amRNSTotal Voting Rights
21st Apr 20231:08 pmRNSNotice of AGM
22nd Mar 20237:00 amRNSFY22 Preliminary Results to 31 December 2022
8th Mar 20239:49 amRNSHolding(s) in Company
8th Feb 20232:56 pmRNSStandard form for notification of major holdings
30th Jan 20234:32 pmRNSHolding(s) in Company
26th Jan 20237:00 amRNSFY22 pre-close trading update
17th Jan 20239:45 amRNSStandard form for notification of major holdings
19th Dec 20227:00 amRNSBlock Admission Application
12th Dec 20227:00 amRNSDomenic De Lorenzo to succeed Bill Ronald as Chair
1st Dec 20229:00 amRNSBlock Listing Return
21st Nov 20227:00 amRNSChange Of Nominated Advisor and Corporate Broker
15th Nov 20226:18 pmRNSStandard form for notification of major holdings
1st Nov 20227:00 amRNSTotal Voting Rights
17th Oct 20223:09 pmRNSStandard form for notification of major holdings
4th Oct 202210:25 amRNSDirector/PDMR Shareholding
3rd Oct 20229:00 amRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSFever-Tree FY22 Interim Results
1st Sep 20227:00 amRNSTotal Voting Rights
24th Aug 202212:06 pmRNSStandard form for notification of major holdings
19th Jul 20229:57 amRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSDirector/PDMR Shareholding
15th Jul 20224:00 pmRNSDirector/PDMR Shareholding
15th Jul 202210:14 amRNSDirector/PDMR Shareholding
15th Jul 20227:00 amRNSHY pre-close trading update
1st Jul 20222:26 pmRNSFever Tree drinks plc Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.